233 related articles for article (PubMed ID: 30902279)
1. Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
Perez JL; Jayaprakasha GK; Patil BS
Food Chem; 2019 Aug; 288():178-186. PubMed ID: 30902279
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bitter melon (Momordica charantia) cultivars grown in Texas and levels of various phytonutrients.
Perez JL; Jayaprakasha GK; Crosby K; Patil BS
J Sci Food Agric; 2019 Jan; 99(1):379-390. PubMed ID: 29888551
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
Kenny O; Smyth TJ; Hewage CM; Brunton NP
Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
[TBL] [Abstract][Full Text] [Related]
4. Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.
Zhou S; Allard PM; Wolfrum C; Ke C; Tang C; Ye Y; Wolfender JL
Metabolomics; 2019 Jul; 15(8):104. PubMed ID: 31321563
[TBL] [Abstract][Full Text] [Related]
5. Thermal treatment enhances the α-glucosidase inhibitory activity of bitter melon (Momordica charantia) by increasing the free form of phenolic compounds and the contents of Maillard reaction products.
Hsieh HJ; Lin JA; Chen KT; Cheng KC; Hsieh CW
J Food Sci; 2021 Jul; 86(7):3109-3121. PubMed ID: 34146408
[TBL] [Abstract][Full Text] [Related]
6. Greenhouse-grown bitter melon: production and quality characteristics.
Tan SP; Parks SE; Stathopoulos CE; Roach PD
J Sci Food Agric; 2014 Jul; 94(9):1896-903. PubMed ID: 24302224
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Biological Activities of Wild Bitter Melon (
Pham TMH; Ngo DH; Ngo DN; Vo TS
Biomolecules; 2019 May; 9(6):. PubMed ID: 31151277
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
Poovitha S; Parani M
BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
[TBL] [Abstract][Full Text] [Related]
9. Extraction, quantification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia) harvested at three maturity stages (immature, mature, and ripe).
Horax R; Hettiarachchy N; Chen P
J Agric Food Chem; 2010 Apr; 58(7):4428-33. PubMed ID: 20225855
[TBL] [Abstract][Full Text] [Related]
10. Optimized aqueous extraction of saponins from bitter melon for production of a saponin-enriched bitter melon powder.
Tan SP; Vuong QV; Stathopoulos CE; Parks SE; Roach PD
J Food Sci; 2014 Jul; 79(7):E1372-81. PubMed ID: 25041538
[TBL] [Abstract][Full Text] [Related]
11. Quadruple high-resolution α-glucosidase/α-amylase/PTP1B/radical scavenging profiling combined with high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy for identification of antidiabetic constituents in crude root bark of Morus alba L.
Zhao Y; Kongstad KT; Jäger AK; Nielsen J; Staerk D
J Chromatogr A; 2018 Jun; 1556():55-63. PubMed ID: 29729863
[TBL] [Abstract][Full Text] [Related]
12. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K; Kumar D; Agarwal R
Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
[TBL] [Abstract][Full Text] [Related]
13. NMR-based metabolomic profiling of the differential concentration of phytomedicinal compounds in pericarp, skin and seeds of
Mishra S; Ankit ; Sharma R; Gogna N; Dorai K
Nat Prod Res; 2022 Jan; 36(1):390-395. PubMed ID: 33438465
[No Abstract] [Full Text] [Related]
14. Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches.
Shivanagoudra SR; Perera WH; Perez JL; Athrey G; Sun Y; Jayaprakasha GK; Patil BS
Bioorg Chem; 2019 Jun; 87():31-42. PubMed ID: 30856374
[TBL] [Abstract][Full Text] [Related]
15. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
[TBL] [Abstract][Full Text] [Related]
17. Antiglycation and Antioxidant Properties of Momordica charantia.
Aljohi A; Matou-Nasri S; Ahmed N
PLoS One; 2016; 11(8):e0159985. PubMed ID: 27513747
[TBL] [Abstract][Full Text] [Related]
18. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
Uebanso T; Arai H; Taketani Y; Fukaya M; Yamamoto H; Mizuno A; Uryu K; Hada T; Takeda E
J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):482-8. PubMed ID: 18202535
[TBL] [Abstract][Full Text] [Related]
19. Bitter melon (Momordica charantia): a review of efficacy and safety.
Basch E; Gabardi S; Ulbricht C
Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
